• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

RNA结合蛋白RPS7通过依赖赖氨氧化酶样蛋白2(LOXL2)激活整合素β1(ITGB1)/黏着斑激酶(FAK)/Src信号通路促进肝细胞癌进展。

RNA-binding protein RPS7 promotes hepatocellular carcinoma progression via LOXL2-dependent activation of ITGB1/FAK/SRC signaling.

作者信息

Zhou Yu-Jiao, Yang Min-Li, He Xin, Gu Hui-Ying, Ren Ji-Hua, Cheng Sheng-Tao, Fu Zhou, Zhang Zhen-Zhen, Chen Juan

机构信息

Department of Infectious Disease, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Child Rare Diseases in Infection and Immunity, No.20 Jinyu Road, Yubei District, Chongqing, 401122, China.

The Key Laboratory of Molecular Biology of Infectious Diseases designated by the Chinese Ministry of Education, Chongqing Medical University, Chongqing, China.

出版信息

J Exp Clin Cancer Res. 2024 Feb 8;43(1):45. doi: 10.1186/s13046-023-02929-1.

DOI:10.1186/s13046-023-02929-1
PMID:38326908
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10851485/
Abstract

BACKGROUND

Metastasis is one of the leading cause contributes to treatment failure and poor prognosis of hepatocellular carcinoma (HCC) patients. The underlying mechanism of HCC metastasis remains to be determined. Although several RNA binding proteins (RBPs) have been found to participate in tumorigenesis and progression of liver cancer, the role of RBPs in HCC patients with extrahepatic metastases is poorly understood.

METHODS

By performing RNA-seq of primary HCC tissues (including HCC with extrahepatic metastasis and those did not develop metastasis), we identified a set of HCC metastasis-associated RBPs candidates. Among which, ribosomal protein S7 (RPS7) was found to be remarkably increased in HCC tissues and be strongly related to HCC poor survival. Overexpression or CRISPR-Cas9-mediated knockout were applied to investigate the role of RPS7 on the metastasis-associated phenotypes of HCC cells. RNA sequencing, RIP, RNA-pull down, dual luciferase reporter assay, nascent RNA capture assay, and RNA decay and so on, were applied to reveal the underlying mechanism of RPS7 induced HCC metastasis.

RESULTS

Gain- and loss- of function analyses revealed that RPS7 promoted HCC cells adhesion, migration and invasion capabilities, as well as lung metastasis. Mechanistically, we uncovered that lysyl oxidase-like 2 (LOXL2) was a critical downstream target of RPS7. RPS7 could stabilize LOXL2 mRNA by binding to AUUUA motifs in the 3155-3375 region of the 3'UTR of LOXL2 mRNA, thus increased LOXL2 expression via elevating LOXL2 mRNA abundance. Further research revealed that LOXL2 could accelerate focal adhesion formation through maintaining the protein stability of ITGB1 and activating ITGB1-mediated FAK/SRC signaling pathway, and thereby contribute to the pro-metastasis effect of RPS7.

CONCLUSIONS

Taken together, our data reveal a novel function of RPS7 in HCC metastasis, also reveal the critical roles of the RPS7/LOXL2/ITGB1 axis in HCC metastasis and shed new light on the exploration of molecular drugs against HCC.

摘要

背景

转移是导致肝细胞癌(HCC)患者治疗失败和预后不良的主要原因之一。HCC转移的潜在机制仍有待确定。尽管已发现几种RNA结合蛋白(RBPs)参与肝癌的发生和发展,但RBPs在伴有肝外转移的HCC患者中的作用仍知之甚少。

方法

通过对原发性HCC组织(包括伴有肝外转移的HCC和未发生转移的HCC)进行RNA测序,我们鉴定出一组与HCC转移相关的RBPs候选物。其中,核糖体蛋白S7(RPS7)在HCC组织中显著增加,且与HCC患者的不良生存密切相关。应用过表达或CRISPR-Cas9介导的敲除来研究RPS7对HCC细胞转移相关表型的作用。采用RNA测序、RNA免疫沉淀、RNA下拉、双荧光素酶报告基因检测、新生RNA捕获检测以及RNA降解等方法,揭示RPS7诱导HCC转移的潜在机制。

结果

功能获得和功能缺失分析表明,RPS7促进HCC细胞的黏附、迁移和侵袭能力以及肺转移。机制上,我们发现赖氨酰氧化酶样2(LOXL2)是RPS7的关键下游靶点。RPS7可通过与LOXL2 mRNA 3'UTR的3155 - 3375区域中的AUUUA基序结合来稳定LOXL2 mRNA,从而通过提高LOXL2 mRNA丰度增加LOXL2表达。进一步研究表明,LOXL2可通过维持整合素β1(ITGB1)的蛋白质稳定性并激活ITGB1介导的黏着斑激酶/原癌基因酪氨酸蛋白激酶Src(FAK/SRC)信号通路来加速黏着斑形成,从而促进RPS7的促转移作用。

结论

综上所述,我们的数据揭示了RPS7在HCC转移中的新功能,也揭示了RPS7/LOXL2/ITGB1轴在HCC转移中的关键作用,并为抗HCC分子药物的探索提供了新的思路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b8f/10851485/6dd21f720ff9/13046_2023_2929_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b8f/10851485/cb27eb24b5be/13046_2023_2929_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b8f/10851485/d80ed973e1a8/13046_2023_2929_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b8f/10851485/a62876c10749/13046_2023_2929_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b8f/10851485/1e3d2253742d/13046_2023_2929_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b8f/10851485/259d5d3a72ad/13046_2023_2929_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b8f/10851485/f7545372e692/13046_2023_2929_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b8f/10851485/a449893dbe26/13046_2023_2929_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b8f/10851485/6dd21f720ff9/13046_2023_2929_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b8f/10851485/cb27eb24b5be/13046_2023_2929_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b8f/10851485/d80ed973e1a8/13046_2023_2929_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b8f/10851485/a62876c10749/13046_2023_2929_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b8f/10851485/1e3d2253742d/13046_2023_2929_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b8f/10851485/259d5d3a72ad/13046_2023_2929_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b8f/10851485/f7545372e692/13046_2023_2929_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b8f/10851485/a449893dbe26/13046_2023_2929_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b8f/10851485/6dd21f720ff9/13046_2023_2929_Fig8_HTML.jpg

相似文献

1
RNA-binding protein RPS7 promotes hepatocellular carcinoma progression via LOXL2-dependent activation of ITGB1/FAK/SRC signaling.RNA结合蛋白RPS7通过依赖赖氨氧化酶样蛋白2(LOXL2)激活整合素β1(ITGB1)/黏着斑激酶(FAK)/Src信号通路促进肝细胞癌进展。
J Exp Clin Cancer Res. 2024 Feb 8;43(1):45. doi: 10.1186/s13046-023-02929-1.
2
HIF-1α promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment.在缺氧肿瘤微环境中,缺氧诱导因子-1α(HIF-1α)通过上调赖氨酰氧化酶样蛋白2(LOXL2)促进肝细胞癌中的血管生成拟态形成。
J Exp Clin Cancer Res. 2017 Apr 27;36(1):60. doi: 10.1186/s13046-017-0533-1.
3
Exosome-mediated secretion of LOXL4 promotes hepatocellular carcinoma cell invasion and metastasis.外泌体介导的 LOXL4 分泌促进肝癌细胞侵袭和转移。
Mol Cancer. 2019 Jan 31;18(1):18. doi: 10.1186/s12943-019-0948-8.
4
Impedes Metastatic Behaviors in Hepatocellular Carcinoma via Targeting , , and .通过靶向 、 和 抑制肝癌的转移行为。
Int J Mol Sci. 2021 Jun 1;22(11):6001. doi: 10.3390/ijms22116001.
5
Secreted LOXL2 is a novel therapeutic target that promotes gastric cancer metastasis via the Src/FAK pathway.分泌型LOXL2是一种通过Src/FAK途径促进胃癌转移的新型治疗靶点。
Carcinogenesis. 2009 Oct;30(10):1660-9. doi: 10.1093/carcin/bgp178. Epub 2009 Jul 22.
6
LOXL2 promotes vasculogenic mimicry and tumour aggressiveness in hepatocellular carcinoma.LOXL2 促进肝癌中的血管生成拟态和肿瘤侵袭性。
J Cell Mol Med. 2019 Feb;23(2):1363-1374. doi: 10.1111/jcmm.14039. Epub 2018 Dec 1.
7
Silencing of lysyl oxidase‑like 2 inhibits the migration, invasion and epithelial‑to‑mesenchymal transition of renal cell carcinoma cells through the Src/FAK signaling pathway.赖氨酸氧化酶样蛋白 2 的沉默通过Src/FAK 信号通路抑制肾癌细胞的迁移、侵袭和上皮-间质转化。
Int J Oncol. 2019 May;54(5):1676-1690. doi: 10.3892/ijo.2019.4726. Epub 2019 Feb 27.
8
LOXL2 serves as a prognostic biomarker for hepatocellular carcinoma by mediating immune infiltration and vasculogenic mimicry.赖氨酰氧化酶样蛋白2(LOXL2)通过介导免疫浸润和血管生成拟态,作为肝细胞癌的预后生物标志物。
Dig Liver Dis. 2023 May;55(5):661-672. doi: 10.1016/j.dld.2022.09.003. Epub 2022 Oct 1.
9
The pathological significance of LOXL2 in pre-metastatic niche formation of HCC and its related molecular mechanism.LOXL2 在 HCC 转移前微环境形成中的病理意义及其相关分子机制。
Eur J Cancer. 2021 Apr;147:63-73. doi: 10.1016/j.ejca.2021.01.011. Epub 2021 Feb 19.
10
Lysyl oxidase-like 2 is critical to tumor microenvironment and metastatic niche formation in hepatocellular carcinoma.赖氨酰氧化酶样蛋白 2 对于肝癌肿瘤微环境和转移灶形成至关重要。
Hepatology. 2014 Nov;60(5):1645-58. doi: 10.1002/hep.27320. Epub 2014 Oct 2.

引用本文的文献

1
CHML regulates migration and invasion in hepatocellular carcinoma via transcriptional and metabolic reprogramming.CHML通过转录和代谢重编程调节肝癌中的迁移和侵袭。
Front Oncol. 2025 Aug 6;15:1575809. doi: 10.3389/fonc.2025.1575809. eCollection 2025.
2
Exploring RNA binding proteins in hepatocellular carcinoma: insights into mechanisms and therapeutic potential.探索肝细胞癌中的RNA结合蛋白:对其机制及治疗潜力的见解
J Exp Clin Cancer Res. 2025 Apr 24;44(1):130. doi: 10.1186/s13046-025-03395-7.
3
The role of RNA binding proteins in cancer biology: A focus on FMRP.

本文引用的文献

1
Loss of LOXL2 Promotes Uterine Hypertrophy and Tumor Progression by Enhancing H3K36ac-Dependent Gene Expression.LOXL2 缺失通过增强 H3K36ac 依赖性基因表达促进子宫肥大和肿瘤进展。
Cancer Res. 2022 Dec 2;82(23):4400-4413. doi: 10.1158/0008-5472.CAN-22-0848.
2
HGF-mediated elevation of ETV1 facilitates hepatocellular carcinoma metastasis through upregulating PTK2 and c-MET.HGF 介导的 ETV1 上调促进肝细胞癌转移通过上调 PTK2 和 c-MET。
J Exp Clin Cancer Res. 2022 Sep 16;41(1):275. doi: 10.1186/s13046-022-02475-2.
3
Splice-site variant in the RPS7 5'-UTR leads to a decrease in the mRNA level and development of Diamond-Blackfan anemia.
RNA结合蛋白在癌症生物学中的作用:聚焦于脆性X智力低下蛋白(FMRP)
Genes Dis. 2024 Dec 21;12(4):101493. doi: 10.1016/j.gendis.2024.101493. eCollection 2025 Jul.
4
Cox-Sage: enhancing Cox proportional hazards model with interpretable graph neural networks for cancer prognosis.Cox-Sage:使用可解释的图神经网络增强Cox比例风险模型以进行癌症预后分析
Brief Bioinform. 2025 Mar 4;26(2). doi: 10.1093/bib/bbaf108.
5
CPEB3 can regulate seizure susceptibility by inhibiting the transcriptional activity of STAT3 on NMDARs expression.CPEB3可通过抑制STAT3对NMDARs表达的转录活性来调节癫痫易感性。
Mol Med. 2025 Feb 24;31(1):77. doi: 10.1186/s10020-025-01136-2.
6
MicroRNAs and RNA-Binding Protein-Based Regulation of Bone Metastasis from Hepatobiliary Cancers and Potential Therapeutic Strategies.基于微小RNA和RNA结合蛋白的肝胆癌骨转移调控及潜在治疗策略
Cells. 2024 Nov 21;13(23):1935. doi: 10.3390/cells13231935.
7
RPS21 Enhances hepatocellular carcinoma development through GPX4 stabilization.核糖体蛋白S21通过稳定谷胱甘肽过氧化物酶4促进肝细胞癌发展。
Transl Oncol. 2025 Jan;51:102189. doi: 10.1016/j.tranon.2024.102189. Epub 2024 Nov 14.
8
The noncanonical RNA-binding protein RAN stabilizes the mRNA of intranuclear stress granule assembly factor G3BP1 in nasopharyngeal carcinoma.非经典RNA结合蛋白RAN可稳定鼻咽癌中核内应激颗粒组装因子G3BP1的mRNA。
J Biol Chem. 2024 Dec;300(12):107964. doi: 10.1016/j.jbc.2024.107964. Epub 2024 Nov 5.
9
Clinical significance of upregulated Rho GTPase activating protein 12 causing resistance to tyrosine kinase inhibitors in hepatocellular carcinoma.Rho GTP酶激活蛋白12上调导致肝细胞癌对酪氨酸激酶抑制剂耐药的临床意义
World J Gastrointest Oncol. 2024 Oct 15;16(10):4244-4263. doi: 10.4251/wjgo.v16.i10.4244.
10
Dissection of the cell communication interactions in lung adenocarcinoma identified a prognostic model with immunotherapy efficacy assessment and a potential therapeutic candidate gene ITGB1.对肺腺癌中细胞通讯相互作用的剖析确定了一个具有免疫治疗疗效评估的预后模型和一个潜在的治疗候选基因ITGB1。
Heliyon. 2024 Aug 22;10(17):e36599. doi: 10.1016/j.heliyon.2024.e36599. eCollection 2024 Sep 15.
RPS7 5'-UTR 中的剪接位点变异导致 mRNA 水平降低,并引发 Diamond-Blackfan 贫血。
Clin Genet. 2023 Jan;103(1):93-96. doi: 10.1111/cge.14221. Epub 2022 Sep 12.
4
Loss of RPS27a expression regulates the cell cycle, apoptosis, and proliferation via the RPL11-MDM2-p53 pathway in lung adenocarcinoma cells.RPS27a 表达缺失通过 RPL11-MDM2-p53 通路调控肺腺癌细胞周期、凋亡和增殖。
J Exp Clin Cancer Res. 2022 Jan 24;41(1):33. doi: 10.1186/s13046-021-02230-z.
5
The role of RNA binding proteins in hepatocellular carcinoma.RNA 结合蛋白在肝细胞癌中的作用。
Adv Drug Deliv Rev. 2022 Mar;182:114114. doi: 10.1016/j.addr.2022.114114. Epub 2022 Jan 19.
6
Ribosomal Protein S6: A Potential Therapeutic Target against Cancer?核糖体蛋白 S6:癌症治疗的潜在靶点?
Int J Mol Sci. 2021 Dec 21;23(1):48. doi: 10.3390/ijms23010048.
7
LOXL2-enriched small extracellular vesicles mediate hypoxia-induced premetastatic niche and indicates poor outcome of head and neck cancer.LOXL2 富集的小细胞外囊泡介导低氧诱导的前转移龛,并预示头颈部癌症的不良预后。
Theranostics. 2021 Sep 3;11(19):9198-9216. doi: 10.7150/thno.62455. eCollection 2021.
8
The Ribosomal Protein L28 Gene Induces Sorafenib Resistance in Hepatocellular Carcinoma.核糖体蛋白L28基因诱导肝癌对索拉非尼耐药。
Front Oncol. 2021 Jul 8;11:685694. doi: 10.3389/fonc.2021.685694. eCollection 2021.
9
HIF-1-induced mitochondrial ribosome protein L52: a mechanism for breast cancer cellular adaptation and metastatic initiation in response to hypoxia.缺氧诱导因子-1诱导的线粒体核糖体蛋白L52:乳腺癌细胞适应及响应缺氧引发转移的一种机制
Theranostics. 2021 May 25;11(15):7337-7359. doi: 10.7150/thno.57804. eCollection 2021.
10
Recent Advances in Hepatocellular Carcinoma Treatment.肝细胞癌治疗的最新进展
Clin Gastroenterol Hepatol. 2021 Oct;19(10):2020-2024. doi: 10.1016/j.cgh.2021.05.045. Epub 2021 Jun 9.